Approved indications
Donepezil is FDA‑approved for the treatment of mild, moderate, and severe Alzheimer’s dementia in adults, to help improve or stabilize cognitive function and daily activities.

Off‑label uses
Clinicians sometimes use donepezil off‑label for other dementias (such as dementia with Lewy bodies, Parkinson’s disease dementia, or vascular dementia) and certain cognitive problems after brain injury or stroke; evidence is mixed to modest, and benefits are generally smaller and less certain than in Alzheimer’s disease.

Efficacy expectations and onset
Some patients show improvement or stabilization in memory, thinking, or daily functioning within a few weeks, with typical assessment after about 3 months of treatment; many people experience slowed decline rather than dramatic improvement, and some may not notice clear benefit.

Typical clinical outcomes
On average, donepezil provides modest benefits in standardized memory and function scores, and can delay worsening of symptoms for several months in responders, but it does not stop disease progression or reverse existing damage.

Comparison to similar drugs
Compared with other cholinesterase inhibitors (such as rivastigmine and galantamine), donepezil has similar overall effectiveness, is taken once daily, and is often chosen first because of its convenient dosing and long experience of use; however, individual response and side‑effect tolerability vary, so switching agents may be considered if benefit is inadequate or side effects are problematic.

Typical dosing and titration
For adults with Alzheimer’s dementia, treatment usually starts at 5 mg by mouth once daily (often at bedtime) for at least 4 to 6 weeks; if tolerated, the dose may be increased to 10 mg once daily, and for some patients with moderate to severe disease who have tolerated 10 mg for at least 3 months, a 23 mg once‑daily tablet may be considered.

How to take
Donepezil can be taken with or without food, swallowed whole with water; some formulations are orally disintegrating tablets that dissolve on the tongue and are then swallowed, and doses should be taken at the same time each day, commonly in the evening, though morning dosing may be chosen if sleep disturbance occurs.

Special dosing instructions
Dose increases should be gradual to reduce side effects, and people who are very thin, frail, or prone to side effects may remain on a lower maintenance dose; if treatment is interrupted for several days or longer, the prescriber may restart at a lower dose and retitrate.

Missed dose guidance
If a once‑daily dose is missed, it is generally taken when remembered on the same day unless it is close to the time for the next dose, in which case the missed dose is skipped and the regular schedule resumed; double doses should not be taken to make up for a missed one.

Overdose
Symptoms of overdose may include severe nausea, vomiting, drooling, sweating, very slow heart rate, breathing difficulty, muscle weakness, fainting, or seizures; in case of suspected overdose, emergency medical care should be sought immediately or poison control contacted for urgent guidance.

Common side effects
Common side effects include nausea, vomiting, diarrhea, loss of appetite, weight loss, insomnia, muscle cramps, fatigue, dizziness, and increased sweating, often occurring when treatment is started or the dose is increased; these are usually mild to moderate and may lessen over days to weeks.

Serious or rare adverse effects
Serious effects that require urgent medical attention include fainting or near‑fainting, very slow heartbeat, chest pain, new or worsening breathing problems (especially in people with asthma or COPD), seizures, severe vomiting or diarrhea with dehydration, black or bloody stools, vomiting blood, or signs of stomach or intestinal bleeding, and signs of allergic reaction such as rash, swelling of the face or throat, or trouble breathing.

Warnings and precautions
Use caution in people with heart rhythm problems (such as sick sinus syndrome, AV block), a history of ulcers or gastrointestinal bleeding, asthma or COPD, seizures, low body weight, or liver disease; in pregnancy, donepezil is used only if clearly needed, and information in breastfeeding is limited, so risks and benefits should be carefully discussed with the prescriber.

Age considerations
Donepezil is intended for adults with dementia; safety and effectiveness in children have not been established, and older adults may be more sensitive to side effects such as slow heart rate, falls, and weight loss.

Relative safety vs. alternatives
Compared with other cholinesterase inhibitors, donepezil has a similar side‑effect profile (notably gastrointestinal and heart‑rate effects) and is generally well tolerated at standard doses, though some individuals may do better with a different agent or formulation.

Side‑effect reporting and safety updates
Patients and caregivers should report troublesome or serious side effects promptly to their prescriber or pharmacist, and they can also report suspected adverse effects directly to the FDA’s MedWatch program or check FDA and manufacturer communications for new safety information.

Prescription drug interactions
Donepezil can increase the risk of slow heart rate when combined with other medicines that affect heart rhythm (such as certain beta‑blockers, some antiarrhythmics, or some calcium channel blockers), and its levels may be affected by strong inhibitors or inducers of certain liver enzymes (such as some antifungals, macrolide antibiotics, or anticonvulsants), so prescribers should review the full medication list.

OTC medicines and supplements
Nonsteroidal anti‑inflammatory drugs (NSAIDs) like ibuprofen or naproxen may increase the risk of stomach or intestinal bleeding when taken with donepezil; some supplements or herbal products that affect heart rate or have anticholinergic effects (such as diphenhydramine‑containing sleep aids) may counteract or complicate treatment and should be discussed with a clinician.

Food, alcohol, and procedures
There are no major food restrictions with donepezil, and it may be taken with or without meals; alcohol should be limited because it can worsen confusion or dizziness, and patients should inform anesthesiologists and other specialists that they take donepezil before surgery or certain procedures, as it may interact with neuromuscular blocking agents.

Precautions and conditions requiring caution
Caution is advised in people with heart conduction disorders, history of fainting, peptic ulcer disease or gastrointestinal bleeding, asthma or COPD, seizures, or significant liver impairment, and clinicians may adjust therapy or monitor more closely in these settings.

Monitoring needs
Before and during treatment, clinicians may monitor for slow heart rate, weight loss, gastrointestinal symptoms, sleep changes, and changes in cognition and daily functioning; in some patients with cardiac history, an electrocardiogram (ECG) or closer cardiovascular monitoring may be recommended.

Q: Does donepezil cure Alzheimer’s disease?
A: No, donepezil does not cure Alzheimer’s disease or stop it from progressing; it may help improve or stabilize memory, thinking, and daily function for a period of time in some people.

Q: How long does it take for donepezil to start working?
A: Some improvement or stabilization may be noticed within a few weeks, but doctors often assess benefit after about 2 to 3 months of regular use at a stable dose.

Q: Should donepezil be taken in the morning or at night?
A: It is commonly taken once daily at bedtime, but if it causes vivid dreams or insomnia, a clinician may recommend switching to morning dosing.

Q: What happens if donepezil is stopped suddenly?
A: Stopping donepezil usually does not cause withdrawal, but memory and thinking may gradually worsen back to the underlying disease course, so any change in therapy should be discussed with the prescriber.

Q: Can donepezil be used with new Alzheimer’s treatments like monoclonal antibodies?
A: In some cases, doctors may continue donepezil while adding other Alzheimer’s treatments, but this decision is individualized based on potential benefits, side effects, and overall health.

Storage
Store tablets at room temperature (generally 68°F to 77°F / 20°C to 25°C), in a dry place away from moisture, heat, and direct light, and keep the medication in its original, tightly closed container.

Child safety
Keep out of reach of children and pets; use child‑resistant caps and do not leave doses in pill organizers where children can access them.

Disposal
Do not flush donepezil down the toilet unless specifically instructed; instead, use a local drug take‑back program or follow pharmacy/FDA guidelines for mixing unused tablets with something unappealing (like coffee grounds or cat litter), sealing in a bag, and placing in household trash.